V体育2025版 - Advances in the prevention of Alzheimer's disease and dementia
- PMID: 24605807
- PMCID: PMC4390027
- DOI: 10.1111/joim.12178
"V体育2025版" Advances in the prevention of Alzheimer's disease and dementia
V体育ios版 - Abstract
Background: Definitions and diagnostic criteria for all medical conditions are regularly subjected to reviews and revisions as knowledge advances. In the field of Alzheimer's disease (AD) research, it has taken almost three decades for diagnostic nomenclature to undergo major re-examination. The shift towards presymptomatic and pre-dementia stages of AD has brought prevention and treatment trials much closer to each other than before. VSports手机版.
Methods: Here we discuss: (i) the impact of diagnostic reliability on the possibilities for developing preventive strategies for AD; (ii) the scientific evidence to support moving from observation to action; (iii) ongoing intervention studies; and (iv) the methodological issues and prospects for balancing strategies for high-risk individuals with those for broad population-based prevention V体育安卓版. .
Results: The associations between neuropathology and cognition are still not entirely clear. In addition, the risk factors for AD dementia and the neuropathological hallmarks of AD may not necessarily be the same. Cognitive impairment has a clearer clinical significance and should therefore remain the main focus of prevention V体育ios版. Risk/protective factors for dementia/AD need to be studied from a life-course perspective. New approaches in prevention trials include enrichment strategies based on genetic risk factors or beta-amyloid biomarkers (at least four ongoing pharmacological trials), and multidomain interventions simultaneously targeting various vascular and lifestyle-related risk factors (at least three ongoing trials). Experience from prevention programmes in other chronic diseases can provide additional methodological improvements. .
Conclusions: Building infrastructures for international collaborations is necessary for managing the worldwide public health problem of AD and dementia. The International Database on Aging and Dementia (IDAD) and the European Dementia Prevention Initiative (EDPI) are examples of ongoing international efforts aiming to improve the methodology of preventive studies and provide the basis for larger intervention trials VSports最新版本. .
Keywords: Alzheimer's disease; biomarkers; clinical trials; dementia; prevention V体育平台登录. .
© 2014 The Association for the Publication of the Journal of Internal Medicine. VSports注册入口.
"VSports在线直播" Conflict of interest statement
I. Skoog has been on the speaker’s bureau for Takeda, Esai, Shire, Lundbeck, Jansen and Pfizer V体育官网入口.
He has been a consultant fo Takeda.
S. Andrieu has received consulting fees or payment or institutional grant from Beaufour Ipsen Pharma SAS; Esai Inc; Pierre Fabre Laboratories; Pfizer, Eli Lilly and Company, Lundbeck Inc VSports在线直播. ; Nestle S. A. ; Novartis; Roche; Servier, Janssen; Exhonit; Chiesi; Sanofi.
VSports app下载 - Figures
"V体育官网入口" References
-
- Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet neurology. 2010;9:1118–27. - PubMed
-
- Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet neurology. 2007;6:734–46. - PubMed
"VSports最新版本" Publication types
- "V体育2025版" Actions
V体育安卓版 - MeSH terms
- VSports - Actions
- VSports app下载 - Actions
- "VSports注册入口" Actions
- Actions (V体育官网)
- VSports手机版 - Actions
- "V体育官网入口" Actions
- Actions (VSports最新版本)
- VSports - Actions
Substances
VSports最新版本 - Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
